Prophylaxis for anaphylactoid reactions in high risk patients receiving radiopaque contrast media.
Robertson
P S
PS
Detroit Receiving Hospital, Michigan 48201, USA.
Rhoney
D H
DH
D000707:Anaphylaxis / Q000139:chemically induced* / Q000517:prevention & control*; D018926:Anti-Allergic Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001993:Bronchodilator Agents / Q000627:therapeutic use; D002927:Cimetidine / Q000627:therapeutic use; D003287:Contrast Media / Q000009:adverse effects*; D004155:Diphenhydramine / Q000627:therapeutic use; D004809:Ephedrine / Q000627:therapeutic use; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D011241:Prednisone / Q000627:therapeutic use; D019275:Radiopharmaceuticals / Q000009:adverse effects*; D012306:Risk
D018926:Anti-Allergic Agents; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D003287:Contrast Media; D006633:Histamine Antagonists; D019275:Radiopharmaceuticals; D002927:Cimetidine; D004155:Diphenhydramine; D004809:Ephedrine; D011241:Prednisone